BUY Granules India — Elara Capital, 21 Jul 2026

BUYGranules India

Granules India share price target & all analyst calls

byElara CapitalHorizon: NA (inferred 1 year)21 Jul 2026via Economic Times Stock Recos Overview

Entry₹876Inferred

Target₹977

Total upside +11.53%

Stop lossNot given

CMP₹813.21d ago

Active-7.17%+20.14%upside left 8 mo left

Follow Elara Capital for new calls(100% target hit, 36 closed calls)Get alerts Watch GRANULES for new buy/sell callsGet alerts See 8 other Long-term calls on GRANULES See 273 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:27 am IST

24 supporting12 neutral9 opposing

Supports the BUY call (24)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·13 Nov · yesterday

4 other SEBI-registered advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · same horizon·12 Nov · 2d ago

Zydus Lifesciences, Granules India offer growth opportunities over next 3-5 years: Shanika Capital

NewsCnbc-Tv18·9 Nov · 5d ago

Shanika Capital's Anmol Ganjoo sees Zydus Lifesciences, Granules India among potential pharma winner

NewsCnbc-Tv18·9 Nov · 5d ago

Granules India Q2 Results: Net profit jumps 39% on higher revenue, EBITDA margin improves

NewsCnbc-Tv18·2 Nov · 2w ago

Neutral / worth noting (12)

Granules India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·2 Nov · 2w ago

Granules India's Gagillapur facility received 11 observations from the USFDA following an inspection. The company stated none relate to data integrity or cross-contamination and there is no impact on

BSE · Company Update·30 Oct · 2w ago

Granules India Gagillapur FDA Inspection and Manufacturing Compliance Explained

NewsGoogle News·19 Oct · 4w ago

Weighs against the BUY call (9)

Here's why Granules India shares could see a reaction on Monday

NewsCnbc-Tv18·31 Oct · 2w ago

Granules India’s Gagillapur facility gets 11 observations in USFDA inspection

NewsCnbc-Tv18·30 Oct · 2w ago

Granules India's Gagillapur manufacturing facility received eleven observations from the USFDA following an inspection.

NSE · Press Release·30 Oct · 2w ago

Granules India Faces US FDA Inspection At Gagillapur Facility

NewsGoogle News·19 Oct · 4w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Granules India

All analyst calls on Granules India

More from Elara Capital

Every call and its outcome